214 related articles for article (PubMed ID: 15914836)
1. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
[TBL] [Abstract][Full Text] [Related]
2. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
Lasfar A; Lewis-Antes A; Smirnov SV; Anantha S; Abushahba W; Tian B; Reuhl K; Dickensheets H; Sheikh F; Donnelly RP; Raveche E; Kotenko SV
Cancer Res; 2006 Apr; 66(8):4468-77. PubMed ID: 16618774
[TBL] [Abstract][Full Text] [Related]
4. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M
PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.
Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W
J Interferon Cytokine Res; 2015 Mar; 35(3):213-21. PubMed ID: 25268605
[TBL] [Abstract][Full Text] [Related]
7. Interferon-λ Attenuates Rabies Virus Infection by Inducing Interferon-Stimulated Genes and Alleviating Neurological Inflammation.
Li Y; Zhao L; Luo Z; Zhang Y; Lv L; Zhao J; Sui B; Huang F; Cui M; Fu ZF; Zhou M
Viruses; 2020 Apr; 12(4):. PubMed ID: 32268591
[TBL] [Abstract][Full Text] [Related]
8. The dynamic changes of interferon lambdas related genes and proteins in JAK/STAT pathway in both acute and chronic HIV-1 infected patients.
Zhao G; Liu L; Su B; Zhang T; Chen P; Li W; Wu H
AIDS Res Ther; 2017 Jun; 14(1):31. PubMed ID: 28623917
[TBL] [Abstract][Full Text] [Related]
9. Lambda-Interferons Inhibit Herpes Simplex Virus Type 2 Replication in Human Cervical Epithelial Cells by Activating the JAK/STAT Pathway.
Li Z; Lu X; Zhu Y; Cheng P; Liu S; Zhang Y; Tang J; Yang S; Zhou L
Jpn J Infect Dis; 2017 Jul; 70(4):416-422. PubMed ID: 28250263
[TBL] [Abstract][Full Text] [Related]
10. The interferon system of teleost fish.
Robertsen B
Fish Shellfish Immunol; 2006 Feb; 20(2):172-91. PubMed ID: 15939626
[TBL] [Abstract][Full Text] [Related]
11. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
Yang L; Wei J; He S
Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
[TBL] [Abstract][Full Text] [Related]
12. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
[TBL] [Abstract][Full Text] [Related]
13. Type III Interferons in Viral Infection and Antiviral Immunity.
Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X
Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714
[TBL] [Abstract][Full Text] [Related]
14. Impact and regulation of lambda interferon response in human metapneumovirus infection.
Baños-Lara Mdel R; Harvey L; Mendoza A; Simms D; Chouljenko VN; Wakamatsu N; Kousoulas KG; Guerrero-Plata A
J Virol; 2015 Jan; 89(1):730-42. PubMed ID: 25355870
[TBL] [Abstract][Full Text] [Related]
15. Interferons lambda, new cytokines with antiviral activity.
Lopušná K; Režuchová I; Betáková T; Skovranová L; Tomašková J; Lukáčiková L; Kabát P
Acta Virol; 2013; 57(2):171-9. PubMed ID: 23600875
[TBL] [Abstract][Full Text] [Related]
16. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
Kotenko SV; Gallagher G; Baurin VV; Lewis-Antes A; Shen M; Shah NK; Langer JA; Sheikh F; Dickensheets H; Donnelly RP
Nat Immunol; 2003 Jan; 4(1):69-77. PubMed ID: 12483210
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Type III Interferon (IFN) Genes
Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
[TBL] [Abstract][Full Text] [Related]
18. Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.
Sakala IG; Chaudhri G; Buller RM; Nuara AA; Bai H; Chen N; Karupiah G
J Virol; 2007 Apr; 81(7):3346-53. PubMed ID: 17229697
[TBL] [Abstract][Full Text] [Related]
19. Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells.
Svetlikova D; Kabat P; Ohradanova A; Pastorek J; Betakova T
Antiviral Res; 2010 Dec; 88(3):329-33. PubMed ID: 20969894
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]